Aequim Alternative Investments’s Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares CLVT.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,000,000
Closed -$29.7M 107
2024
Q1
$29.7M Hold
1,000,000
1.1% 26
2023
Q4
$38.3M Hold
1,000,000
1.52% 22
2023
Q3
$29.2M Hold
1,000,000
1.11% 27
2023
Q2
$41M Hold
1,000,000
1.54% 20
2023
Q1
$41.1M Hold
1,000,000
1.31% 21
2022
Q4
$37.9M Buy
1,000,000
+100,000
+11% +$4.2M 1.03% 30
2022
Q3
$38.4M Hold
900,000
1.11% 30
2022
Q2
$51.5M Hold
900,000
1.58% 21
2022
Q1
$61.1M Buy
900,000
+275,000
+44% +$18.6M 1.61% 23
2021
Q4
$56.8M Buy
+625,000
New +$56.2M 1.77% 17

Aequim Alternative Investments's CLVT.PRA Position: Q2 2024 in Review

Aequim Alternative Investments sold out of Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares (CLVT.PRA) in Q2 2024, closing a stake of 1,000,000 shares — an estimated $29.7M sold.

Aequim Alternative Investments first reported a position in CLVT.PRA in Q4 2021 and held it in 10 quarters. The position peaked at $61.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold CLVT.PRA as of Q2 2024.

  • Aequim Alternative Investments reported no remaining Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position as of Q2 2024 after selling out during the quarter.
  • Aequim Alternative Investments sold 1,000,000 Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares shares in Q2 2024, an estimated $29.7M.
  • Aequim Alternative Investments first reported a position in Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q4 2021 and held it in 10 quarters.
  • Aequim Alternative Investments's Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares position peaked at $61.1M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares as of Q2 2024.

Based on Aequim Alternative Investments's 13F filing for Q2 2024, filed 12 Aug 2024.